\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ surgery\\ only\ \(3\)\
\-\ third\\ ventricular\\ mass\\ with\\ associated\\ hydrocephalus\\.\ \(0\)\
\-\ mass\\ enhances\\ following\\ contrast\\ administration\\.\ \(1\)\
\-\ tanycytic\\ ependymoma\ \(1\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ papilloma\ \(4\)\
\-\ \\â\\€\\¢\\ astrocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ central\\ neurocytoma\ \(2\)\
\-\ 27\\ year\\ old\\ female\\ referred\\ to\\ neurosurgery\\ with\\ third\\ ventricular\\ tumor\ \(0\)\
\-\ the\\ \\"tanycytic\\ ependymoma\\"\\ is\\ an\\ uncommon\\ subtype\\ of\\ ependymoma\\ with\\ a\\ fibrillary\\ appearance\\ and\\ piloid\\ or\\ \\"hair\\-like\\"\\ cells\\.\\ \\ rosette\\ formation\\ is\\ rare\\ compared\\ to\\ other\\ types\\ of\\ ependymoma\\.\\ \\ the\\ prognosis\\ is\\ probably\\ similar\\ to\\ other\\ ependymomas\\.\\ \\ pmid\\:\\ 15690137\ \(0\)\
\-\ http\\:\\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/pubmed\\/9090024\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ependymoma\\:\\ 0\\.46927287254981936\ \(0\)\
\-\ tanycytic\\:\\ 0\\.35537958928038993\ \(0\)\
\-\ ventricular\\:\\ 0\\.18692739106347947\ \(0\)\
\-\ piloid\\:\\ 0\\.17768979464019496\ \(0\)\
\-\ 15690137\\:\\ 0\\.17768979464019496\ \(0\)\
\-\ third\\:\\ 0\\.16920263265992547\ \(0\)\
\-\ rosette\\:\\ 0\\.15984214746328543\ \(0\)\
\-\ fibrillary\\:\\ 0\\.1562908610590808\ \(0\)\
\-\ ependymomas\\:\\ 0\\.14448445771230842\ \(0\)\
\-\ subtype\\:\\ 0\\.13098323382128407\ \(0\)\
\-\ neurocytoma\\:\\ 0\\.12430330494459939\ \(0\)\
\-\ pmid\\:\\ 0\\.12193942011901651\ \(0\)\
\-\ other\\:\\ 0\\.11540287868365831\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.11243986451826099\ \(0\)\
\-\ probably\\:\\ 0\\.10788947969591797\ \(0\)\
\-\ choroid\\:\\ 0\\.10420339587654658\ \(0\)\
\-\ types\\:\\ 0\\.1033278260570885\ \(0\)\
\-\ papilloma\\:\\ 0\\.10188433995165716\ \(0\)\
\-\ uncommon\\:\\ 0\\.10054048653790235\ \(0\)\
\-\ plexus\\:\\ 0\\.10017296339386826\ \(0\)\
\-\ enhances\\:\\ 0\\.09793954220909822\ \(0\)\
\-\ prognosis\\:\\ 0\\.09777789689339753\ \(0\)\
\-\ is\\:\\ 0\\.09128505293929169\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.0907021719855222\ \(0\)\
\-\ 27\\:\\ 0\\.0900418325190084\ \(0\)\
\-\ compared\\:\\ 0\\.08982660216606415\ \(0\)\
\-\ administration\\:\\ 0\\.08848274875230935\ \(0\)\
\-\ formation\\:\\ 0\\.08808723975755069\ \(0\)\
\-\ cells\\:\\ 0\\.08560903149177343\ \(0\)\
\-\ mass\\:\\ 0\\.08488244978299006\ \(0\)\
\-\ similar\\:\\ 0\\.08468332970903715\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.08387833296951325\ \(0\)\
\-\ rare\\:\\ 0\\.08387833296951325\ \(0\)\
\-\ to\\:\\ 0\\.08333218098998695\ \(0\)\
\-\ meningioma\\:\\ 0\\.08325746291620793\ \(0\)\
\-\ referred\\:\\ 0\\.08221639804636605\ \(0\)\
\-\ http\\:\\ 0\\.0821441228289186\ \(0\)\
\-\ central\\:\\ 0\\.07419837822236748\ \(0\)\
\-\ only\\:\\ 0\\.06941550470225225\ \(0\)\
\-\ appearance\\:\\ 0\\.06698418247951865\ \(0\)\
\-\ following\\:\\ 0\\.06665570675668732\ \(0\)\
\-\ with\\:\\ 0\\.06527044421951948\ \(0\)\
\-\ surgery\\:\\ 0\\.05973767616348926\ \(0\)\
\-\ associated\\:\\ 0\\.058563538059601225\ \(0\)\
\-\ tumor\\:\\ 0\\.05811721070403806\ \(0\)\
\-\ contrast\\:\\ 0\\.05398629793346797\ \(0\)\
\-\ female\\:\\ 0\\.05361591575152184\ \(0\)\
\-\ the\\:\\ 0\\.04434112072122731\ \(0\)\
\-\ of\\:\\ 0\\.04348764562178318\ \(0\)\
\-\ an\\:\\ 0\\.04248826222117215\ \(0\)\
\-\ or\\:\\ 0\\.03865334626964349\ \(0\)\
\-\ year\\:\\ 0\\.03424205239428786\ \(0\)\
\-\ old\\:\\ 0\\.03288422347910798\ \(0\)\
\-\ and\\:\\ 0\\.0229596136909085\ \(0\)\
